Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC)

Overgaard Jens; Alsner Jan

首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC)

【24h】

Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC)

机译：ESA作为放射治疗的调理剂的疗效治疗头部鳞状细胞癌（HNSCC）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology 》 |2019年第2019期| 共2页
作者
Overgaard Jens; Alsner Jan;
展开▼
作者单位

Aarhus Univ Hosp Dept Expt Clin Oncol Norrebrogade 44 Bldg 5 DK-8000 Aarhus C Denmark;

Aarhus Univ Hosp Dept Expt Clin Oncol Norrebrogade 44 Bldg 5 DK-8000 Aarhus C Denmark;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC) [J] . Overgaard Jens, Alsner Jan Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2019 ,第期

机译：ESA作为放射治疗的调理剂的疗效治疗头部鳞状细胞癌（HNSCC）
2. The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times. [J] . Eriksen JG, Alsner J, Steiniche T, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2005 ,第2期

机译：TP53突变状态可能在不同总治疗时间的放疗中治疗头颈部鳞状细胞癌（HNSCC）。
3. Outcomes of curative (chemo)radiotherapy for patients with non‐p16 positive head and neck squamous cell carcinoma who are borderline for curative treatment [J] . Xing Daniel, Tiong Albert, Bressel Mathias, Journal of medical imaging and radiation oncology . 2020 ,第2期

机译：治疗（化疗）放射治疗的非P16阳性头部和颈部鳞状细胞癌的疗法的结果
4. Intelligent analysis of methylation data in Head and Neck Squamous Cell Carcinoma (HNSCC) interactomes [C] . Saad Zaheer, Sabaoon Zeb, Faisal F. Khan International Conference on Artificial Intelligence . 2021

机译：头颈鳞状细胞癌（HNSCC）椎间囊组致甲基化数据智能分析
5. Expression of MT1-MMP in Head and Neck Squamous Cell Carcinomas (HNSCCs) and Endothelial Cells is Regulated by Hypoxia and Semaphorin 4D (Sema4D). [D] . Bugshan, Amr. 2016

机译：低氧和Semaphorin 4D（Sema4D）调节头颈部鳞状细胞癌（HNSCC）和内皮细胞中MT1-MMP的表达。
6. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy [O] . Yen-Hao Chen, Hung-I. Lu, Chih-Yen Chien, -1

机译：局部晚期同步食管和头部/颈部鳞状细胞癌接受治疗性并发放化疗的患者的治疗结果
7. Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial [O] . Yungan Tao, Anne Auperin, Pierre Blanchard, 2020

机译：随着强度调节放疗（IMRT）对局部先进头和颈鳞状细胞癌（HTSCC）的常规放疗（HOREC 2004-01随机阶段III试验，并发顺铂和剂量升级与常规放射治疗

Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC)

著录项

相似文献

相关主题

期刊订阅